Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.

@article{Doleal2009EfficacyAT,
  title={Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.},
  author={Jiř{\'i} Dole{\vz}al},
  journal={Onkologie},
  year={2009},
  volume={32 1-2},
  pages={35-9}
}
AIM The aim of this study was to assess the usefulness of (153)samarium-ethylene-diamino-tetramethylene phosphonic acid ((153)Sm-EDTMP, a beta and gamma emitter) treatment in the palliation of painful bone metastases from breast cancer. PATIENTS AND METHODS 43 women (aged 41-79, mean 60 years) with bone-disseminated breast cancer and bone pain refractory to opioid analgesics received (153)Sm-EDTMP. Karnofsky performance status, pain score (numeric rating scale), analgesic score (World Health… CONTINUE READING